Idorsia Ltd ( IDRSF) - Stock Earnings
IDRSF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -108.0 million USD | 52.0 million USD |
| 2025Q4 | -98.4 million USD | 60.5 million USD |
| 2026Q1 | -57.0 million USD | 71.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IDRSF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -354.3 million USD | 181.2 million USD |
| 2024 | -291.7 million USD | 124.4 million USD |
| 2025 | -141.2 million USD | 278.7 million USD |
| 2026 Est. | — | — |
IDRSF
Price: $5.75
52 week price:
Earnings Per Share: -1.31 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion